Blair William & CO 9 Meters Biopharma, Inc. Transaction History

Blair William & CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$0.52 - $1.0 $27,826 - $53,512	-53,512 Reduced 65.33%	28,400 $17,000
Q4 2021 Feb 14, 2022	BUY	$0.85 - $1.33 $45,825 - $71,702	53,912 Added 192.54%	81,912 $80,000
Q1 2021 May 13, 2021	BUY	$0.84 - $2.16 $3,360 - $8,640	4,000 Added 16.67%	28,000 $33,000
Q3 2020 Nov 06, 2020	BUY	$0.48 - $0.84 $11,520 - $20,160	24,000 New	24,000 $20,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

Stay updated on Blair William & CO with notifications on news.